Dataset Information

Minimal lactazole scaffold for in vitro thiopeptide bioengineering.

ABSTRACT: Lactazole A is a cryptic thiopeptide from Streptomyces lactacystinaeus, encoded by a compact 9.8?kb biosynthetic gene cluster. Here, we establish a platform for in vitro biosynthesis of lactazole A, referred to as the FIT-Laz system, via a combination of the flexible in vitro translation (FIT) system with recombinantly produced lactazole biosynthetic enzymes. Systematic dissection of lactazole biosynthesis reveals remarkable substrate tolerance of the biosynthetic enzymes and leads to the development of the minimal lactazole scaffold, a construct requiring only 6 post-translational modifications for macrocyclization. Efficient assembly of such minimal thiopeptides with FIT-Laz opens access to diverse lactazole analogs with 10 consecutive mutations, 14- to 62-membered macrocycles, and 18 amino acid-long tail regions, as well as to hybrid thiopeptides containing non-proteinogenic amino acids. This work suggests that the minimal lactazole scaffold is amenable to extensive bioengineering and opens possibilities to explore untapped chemical space of thiopeptides.

SUBMITTER: Vinogradov AA

PROVIDER: S-EPMC7210931 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Minimal lactazole scaffold for in vitro thiopeptide bioengineering.

Vinogradov Alexander A AA Shimomura Morito M Goto Yuki Y Ozaki Taro T Asamizu Shumpei S Sugai Yoshinori Y Suga Hiroaki H Onaka Hiroyasu H

Nature communications 20200508 1

Lactazole A is a cryptic thiopeptide from Streptomyces lactacystinaeus, encoded by a compact 9.8 kb biosynthetic gene cluster. Here, we establish a platform for in vitro biosynthesis of lactazole A, referred to as the FIT-Laz system, via a combination of the flexible in vitro translation (FIT) system with recombinantly produced lactazole biosynthetic enzymes. Systematic dissection of lactazole biosynthesis reveals remarkable substrate tolerance of the biosynthetic enzymes and leads to the develo ...[more]

PMID: 32385237

Similar Datasets

Project description:Background:Regenerative medicine and tissue engineering are promising approaches for organ transplantation. Extracellular matrix (ECM) based scaffolds obtained through the decellularization of natural organs have become the preferred platform for organ bioengineering. In the field of pancreas bioengineering, acellular scaffolds from different animals approximate the biochemical, spatial and vascular relationships of the native extracellular matrix and have been proven to be a good platform for recellularization and in vitro culture. However, artificial endocrine pancreases based on these whole pancreatic scaffolds have a critical flaw, specifically their difficult in vivo transplantation, and connecting their vessels to the recipient is a major limitation in the development of pancreatic tissue engineering. In this study, we focus on preparing a novel acellular extracellular matrix scaffold derived from the rat pancreatic body tail (pan-body-tail ECM scaffold). Results:Several analyses confirmed that our protocol effectively removes cellular material while preserving ECM proteins and the native vascular tree. DNA quantification demonstrated an obvious reduction of DNA compared with that of the natural organ (from 931.9?±?267.8 to 11.7?±?3.6 ng/mg, P <?0.001); the retention of the sGAG in the decellularized pancreas (0.878?±?0.37) showed no significant difference from the natural pancreas (0.819?±?0.1) (P >?0.05). After transplanted with the recellularized pancreas, fasting glucose levels declined to 9.08?±?2.4 mmol/l within 2 h of the operation, and 8 h later, they had decreased to 4.7?±?1.8 mmol/l (P <?0.05). Conclusions:The current study describes a novel pancreatic ECM scaffold prepared from the rat pancreatic body tail via perfusion through the left gastric artery. We further showed the pioneering possibility of in vivo circulation-connected transplantation of a recellularized pancreas based on this novel scaffold. By providing such a promising pancreatic ECM scaffold, the present study might represent a key improvement and have a positive impact on endocrine pancreas bioengineering.

Dataset Information

Minimal lactazole scaffold for in vitro thiopeptide bioengineering.

Publications

Minimal lactazole scaffold for in vitro thiopeptide bioengineering.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets